Ng P K, Ault M J, Ellrodt A G, Maldonado L
Division of General Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
Mayo Clin Proc. 1997 Mar;72(3):225-33. doi: 10.4065/72.3.225.
To report the success rate and complications associated with peripherally inserted central venous catheters (PICCs) and to compare costs between PICCs and centrally inserted central catheters.
We undertook a cohort study of the first 1,000 patients referred to the PICC service of a large tertiary-care, university-affiliated, community hospital. The data were analyzed for insertion success rate, insertion mode, complication rate, successful completion, insertion costs, and applicability of PICCs in "high-risk" groups (transplant, human immunodeficiency virus-infected, intensive-care unit, and pediatric populations).
Of 1,000 consecutive PICC attempts, 963 (96.3%) were successful. Cutdown procedures were necessary in 141 insertions (14.6%). Complications of PICC placement occurred in 170 cases (17.7%). Among the major complications were a need for multiple attempts at insertion in 92 cases, malpositioning in 56, mechanical phlebitis in 37, clotting in 37, and bleeding in 5. The rate for completion of therapy was 68.9%. Frequent reasons for early termination were dislodgment (in 85 cases) and infection (in 72-37 confirmed and 35 potential cases). The rate of confirmed infection was 11 per 10,000 catheter days. The costs of PICC insertion were less than those associated with centrally inserted central catheters.
PICCs can satisfy long-term vascular needs and are safe in many patient populations. The infection rate did not depend on insertion mode, lumen number, or patient's immune status. Use of total parenteral nutrition was the most important risk factor in all patient subsets. Cost and safety considerations strongly favor PICCs as alternatives to other vascular access devices.
报告外周静脉穿刺中心静脉导管(PICC)的成功率及相关并发症,并比较PICC与中心静脉穿刺中心静脉导管的成本。
我们对一家大型三级医疗、大学附属社区医院PICC服务转诊的前1000例患者进行了队列研究。分析数据的内容包括置管成功率、置管方式、并发症发生率、治疗完成情况、置管成本以及PICC在“高危”人群(移植患者、人类免疫缺陷病毒感染患者、重症监护病房患者和儿科患者)中的适用性。
在连续1000次PICC置管尝试中,963次(96.3%)成功。141次置管(14.6%)需要进行切开手术。PICC置管并发症发生在170例(17.7%)。主要并发症包括92例需要多次置管尝试、56例位置不当、37例机械性静脉炎、37例凝血和5例出血。治疗完成率为68.9%。早期终止的常见原因是导管移位(85例)和感染(72例确诊感染和35例疑似感染)。确诊感染率为每10000导管日11例。PICC置管成本低于中心静脉穿刺中心静脉导管。
PICC可满足长期血管需求,对许多患者群体来说是安全的。感染率不取决于置管方式、管腔数量或患者免疫状态。在所有患者亚组中,使用全胃肠外营养是最重要的危险因素。从成本和安全性考虑,PICC作为其他血管通路装置的替代方案具有很大优势。